LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article ; Online: Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2.

    Pineda Caplliure, Ana / Porcar Almela, Manuel / Navarro Albert, Andrea / Muñoz Vicente, Elvira / Mansilla Roig, Beatriz

    Anales de pediatria

    2021  Volume 94, Issue 6, Page(s) 412–413

    MeSH term(s) COVID-19/diagnostic imaging ; Humans ; Infant, Newborn ; Lung/diagnostic imaging ; Male ; Ultrasonography
    Language English
    Publishing date 2021-04-21
    Publishing country Spain
    Document type Case Reports ; Letter
    ZDB-ID 2830901-7
    ISSN 2341-2879 ; 2341-2879
    ISSN (online) 2341-2879
    ISSN 2341-2879
    DOI 10.1016/j.anpede.2021.04.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Utilidad de la ecografía torácica en infección neonatal por SARS-CoV-2.

    Pineda Caplliure, Ana / Porcar Almela, Manuel / Navarro Albert, Andrea / Muñoz Vicente, Elvira / Mansilla Roig, Beatriz

    Anales de pediatria (Barcelona, Spain : 2003)

    2020  Volume 94, Issue 6, Page(s) 412–413

    Title translation Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2.
    Language Spanish
    Publishing date 2020-06-23
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 2102669-5
    ISSN 1695-9531 ; 1695-4033
    ISSN (online) 1695-9531
    ISSN 1695-4033
    DOI 10.1016/j.anpedi.2020.04.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Utilidad de la ecografía torácica en infección neonatal por SARS-CoV-2

    Pineda Caplliure, Ana / Porcar Almela, Manuel / Navarro Albert, Andrea / Muñoz Vicente, Elvira / Mansilla Roig, Beatriz

    Anales de Pediatría ; ISSN 1695-4033

    2020  

    Keywords Pediatrics, Perinatology, and Child Health ; covid19
    Language Spanish
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.anpedi.2020.04.027
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.

    López-Lacort, Mónica / Muñoz-Quiles, Cintia / Mira-Iglesias, Ainara / López-Labrador, F Xavier / Mengual-Chuliá, Beatriz / Fernández-García, Carlos / Carballido-Fernández, Mario / Pineda-Caplliure, Ana / Mollar-Maseres, Juan / Shalabi Benavent, Maruan / Sanz-Herrero, Francisco / Zornoza-Moreno, Matilde / Pérez-Martín, Jaime Jesús / Alfayate-Miguelez, Santiago / Pérez Crespo, Rocío / Bastida Sánchez, Encarnación / Menasalvas-Ruiz, Ana Isabel / Téllez-González, Mª Cinta / Esquiva Soto, Samuel /
    Del Toro Saravia, Carlos / Sanz-Muñoz, Iván / Eiros, José María / Matías Del Pozo, Vanesa / Toquero-Asensi, Marina / Pastor-Villalba, Eliseo / Lluch-Rodrigo, José Antonio / Díez-Domingo, Javier / Orrico-Sánchez, Alejandro

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

    2024  Volume 29, Issue 6

    Abstract: The monoclonal antibody nirsevimab was at least 70% effective in preventing hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory syncytial virus (RSV) in Spain (Oct 2023-Jan 2024), where a universal ... ...

    Abstract The monoclonal antibody nirsevimab was at least 70% effective in preventing hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory syncytial virus (RSV) in Spain (Oct 2023-Jan 2024), where a universal immunisation programme began late September (coverage range: 79-99%). High protection was confirmed by two methodological designs (screening and test-negative) in a multicentre active surveillance in nine hospitals in three regions. No protection against RSV-negative LRTI-hospitalisations was shown. These interim results could guide public-health decision-making.
    MeSH term(s) Infant ; Humans ; Spain/epidemiology ; Antiviral Agents/therapeutic use ; Respiratory Syncytial Virus Infections/drug therapy ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus, Human ; Hospitalization ; Respiratory Tract Infections/drug therapy ; Respiratory Tract Infections/prevention & control ; Respiratory Tract Infections/epidemiology ; Hospitals ; Antibodies, Monoclonal, Humanized
    Chemical Substances nirsevimab (VRN8S9CW5V) ; Antiviral Agents ; Antibodies, Monoclonal, Humanized
    Language English
    Publishing date 2024-02-09
    Publishing country Sweden
    Document type Journal Article
    ZDB-ID 1338803-4
    ISSN 1560-7917 ; 1025-496X
    ISSN (online) 1560-7917
    ISSN 1025-496X
    DOI 10.2807/1560-7917.ES.2024.29.6.2400046
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Utilidad de la ecografía torácica en infección neonatal por SARS-CoV-2./ [Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2]

    Pineda Caplliure, Ana / Porcar Almela, Manuel / Navarro Albert, Andrea / Muñoz Vicente, Elvira / Mansilla Roig, Beatriz

    An. pediatr. (2003. Ed. impr.)

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #706694
    Database COVID19

    Kategorien

  6. Article ; Online: Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of GAIA Case Definitions: Results and Lessons Learnt of a Hospital-Based Prospective Cohort Study in the Valencia Region (2019-2020).

    Carmona, Antonio / Latorre Tejerina, María / Martínez Sebastián, Alicia / Dobreva, Dafina / Jurca, Cristina P / Huerta Barberá, Sergio / Bernat Montoya, Vicente / Aristoy Zabaleta, Mercedes / Pineda Caplliure, Ana / Mansilla Roig, Beatriz / Navío Anaya, María / Tosca-Segura, Ricardo / Tortajada-Girbés, Miguel / Díez-Domingo, Javier / Orrico-Sánchez, Alejandro

    International journal of environmental research and public health

    2022  Volume 19, Issue 12

    Abstract: Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the ... ...

    Abstract Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the pregnant women population, and particularly due to the recent administration of COVID-19 vaccines in pregnant women. This multi-center prospective cohort study, nested within the WHO-Global Vaccine Safety-MCC study, involved two hospitals in the Valencia region. Hereby, the incidence rates of seven perinatal and neonatal outcomes in the Valencia region are presented. The pooled data analysis of the two Valencian hospitals allowed the estimation of incidence rates in the Valencia Region (per 1000 live births): 86.7 for low birth weight, 78.2 for preterm birth, 58.8 for small for gestational age, 13 for congenital microcephaly, 0.4 for stillbirth, 1.2 for neonatal death and 6.5 for neonatal infection. These figures are in line with what is expected from a high-income country and the previously reported rates for Spain and Europe, except for the significantly increased rate for congenital microcephaly. Regarding the data for maternal immunization, the vaccination status was collected for 94.4% of the screened pregnant women, highlighting the high quality of the Valencian Vaccine Registry. The study also assessed the Valencian hospitals' capacity for identifying and collecting data on maternal immunization status, as well as the applicability of the GAIA definitions to the identified outcomes.
    MeSH term(s) Adolescent ; COVID-19 ; COVID-19 Vaccines ; Female ; Hospitals ; Humans ; Infant, Newborn ; Microcephaly ; Morbidity ; Pregnancy ; Pregnancy Outcome ; Premature Birth/epidemiology ; Prospective Studies ; Vaccines
    Chemical Substances COVID-19 Vaccines ; Vaccines
    Language English
    Publishing date 2022-06-10
    Publishing country Switzerland
    Document type Journal Article ; Multicenter Study
    ZDB-ID 2175195-X
    ISSN 1660-4601 ; 1661-7827
    ISSN (online) 1660-4601
    ISSN 1661-7827
    DOI 10.3390/ijerph19127132
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Oxidative stress in intrauterine growth retardation

    Pineda-Caplliure, Ana / Codoñer-Franch, Pilar

    Journal of Pediatric Biochemistry

    2013  Volume 03, Issue 03, Page(s) 137–142

    Abstract: Intrauterine growth retardation (IUGR) is the failure of the fetus to achieve his/her intrinsic growth potential, due to anatomical and/or functional disorders and diseases in the feto-placental-maternal unit. Fetal growth within the uterus is a complex ... ...

    Abstract Intrauterine growth retardation (IUGR) is the failure of the fetus to achieve his/her intrinsic growth potential, due to anatomical and/or functional disorders and diseases in the feto-placental-maternal unit. Fetal growth within the uterus is a complex biological event influenced by genetic, epigenetic, and environmental factors, as well as maternal nutrition. These factors impact on the size and functional capacity of the placenta, uteroplacental blood flows and transfer of nutrients and oxygen from mother to fetus. Oxidative stress can influence metabolic pathways that alter the epigenetic state (stable alterations of gene expression through DNA methylation and histone modifications) of the fetal genome. This may provide a molecular mechanism for the role of oxidative stress on fetal programming. IUGR results in significant perinatal and long-term complications, including the development of insulin resistance/metabolic syndrome in adulthood. By linking oxidative stress with dysregulation of specific target genes, we may be able to develop therapeutic strategies that protect against organ dysfunction in the programmed offspring.
    Keywords Fetal programming ; intrauterine growth retardation ; metabolic syndrome ; oxidative stress
    Language English
    Publishing date 2013-09-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ISSN 1879-5404 ; 1879-5390
    ISSN (online) 1879-5404
    ISSN 1879-5390
    DOI 10.3233/JPB-130086
    Database Thieme publisher's database

    More links

    Kategorien

  8. Article: Oxidative stress in intrauterine growth retardation

    Pineda-Caplliure, Ana / Codoñer-Franch, Pilar

    Journal of Pediatric Biochemistry

    2013  Volume 03, Issue 03, Page(s) 137–142

    Abstract: Intrauterine growth retardation (IUGR) is the failure of the fetus to achieve his/her intrinsic growth potential, due to anatomical and/or functional disorders and diseases in the feto-placental-maternal unit. Fetal growth within the uterus is a complex ... ...

    Abstract Intrauterine growth retardation (IUGR) is the failure of the fetus to achieve his/her intrinsic growth potential, due to anatomical and/or functional disorders and diseases in the feto-placental-maternal unit. Fetal growth within the uterus is a complex biological event influenced by genetic, epigenetic, and environmental factors, as well as maternal nutrition. These factors impact on the size and functional capacity of the placenta, uteroplacental blood flows and transfer of nutrients and oxygen from mother to fetus. Oxidative stress can influence metabolic pathways that alter the epigenetic state (stable alterations of gene expression through DNA methylation and histone modifications) of the fetal genome. This may provide a molecular mechanism for the role of oxidative stress on fetal programming. IUGR results in significant perinatal and long-term complications, including the development of insulin resistance/metabolic syndrome in adulthood. By linking oxidative stress with dysregulation of specific target genes, we may be able to develop therapeutic strategies that protect against organ dysfunction in the programmed offspring.
    Keywords Fetal programming ; intrauterine growth retardation ; metabolic syndrome ; oxidative stress
    Language English
    Publishing date 2013-09-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ISSN 1879-5404 ; 1879-5390
    ISSN (online) 1879-5404
    ISSN 1879-5390
    DOI 10.1055/s-0036-1586441
    Database Thieme publisher's database

    More links

    Kategorien

  9. Article ; Online: Risk Measurement of Perinatal and Neonatal Morbidity Characteristics and Applicability of GAIA Case Definitions

    Antonio Carmona / María Latorre Tejerina / Alicia Martínez Sebastián / Dafina Dobreva / Cristina P. Jurca / Sergio Huerta Barberá / Vicente Bernat Montoya / Mercedes Aristoy Zabaleta / Ana Pineda Caplliure / Beatriz Mansilla Roig / María Navío Anaya / Ricardo Tosca-Segura / Miguel Tortajada-Girbés / Javier Díez-Domingo / Alejandro Orrico-Sánchez

    International Journal of Environmental Research and Public Health, Vol 19, Iss 7132, p

    Results and Lessons Learnt of a Hospital-Based Prospective Cohort Study in the Valencia Region (2019–2020)

    2022  Volume 7132

    Abstract: Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the ... ...

    Abstract Post-marketing safety surveillance of new vaccines aimed to be administered during pregnancy is crucial to orchestrate efficient adverse events evaluation. This is of special relevance in the current landscape of new vaccines being introduced in the pregnant women population, and particularly due to the recent administration of COVID-19 vaccines in pregnant women. This multi-center prospective cohort study, nested within the WHO-Global Vaccine Safety-MCC study, involved two hospitals in the Valencia region. Hereby, the incidence rates of seven perinatal and neonatal outcomes in the Valencia region are presented. The pooled data analysis of the two Valencian hospitals allowed the estimation of incidence rates in the Valencia Region (per 1000 live births): 86.7 for low birth weight, 78.2 for preterm birth, 58.8 for small for gestational age, 13 for congenital microcephaly, 0.4 for stillbirth, 1.2 for neonatal death and 6.5 for neonatal infection. These figures are in line with what is expected from a high-income country and the previously reported rates for Spain and Europe, except for the significantly increased rate for congenital microcephaly. Regarding the data for maternal immunization, the vaccination status was collected for 94.4% of the screened pregnant women, highlighting the high quality of the Valencian Vaccine Registry. The study also assessed the Valencian hospitals’ capacity for identifying and collecting data on maternal immunization status, as well as the applicability of the GAIA definitions to the identified outcomes.
    Keywords vaccination ; pregnancy ; maternal immunization ; vaccine safety ; standardized case definitions ; incidence rates ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2022-06-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top